Advanced search
Publication Cover
Cancer Biology & Therapy Volume 21, 2020 - Issue 9
Submit an article Journal homepage
2,315
Views
7
CrossRef citations to date
0
Altmetric
Research paper

Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against RET-fusion–positive non–small cell lung cancer cells

Takaaki FujimuraProduct Research Department, Kamakura Research Laboratories, Chugai Pharmaceutical, Kanagawa, Japan
,
Koh FurugakiProduct Research Department, Kamakura Research Laboratories, Chugai Pharmaceutical, Kanagawa, Japan
,
Naoki HaradaProduct Research Department, Kamakura Research Laboratories, Chugai Pharmaceutical, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0003-1468-0636
ORCID Icon &
Yasushi YoshimuraProduct Research Department, Kamakura Research Laboratories, Chugai Pharmaceutical, Kanagawa, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2027-1257
ORCID Icon
Pages 863-870 | Received 06 Sep 2019, Accepted 07 Jul 2020, Published online: 23 Aug 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yourong Zhou, Yiming Yin, Jiangxin Xu, Zhifei Xu, Bo Yang, Qiaojun He, Peihua Luo, Hao Yan & Xiaochun Yang. (2023) An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer. Expert Opinion on Pharmacotherapy 24:12, pages 1361-1373.
Read now

Articles from other publishers (6)

Shashi Kiran Misra, Devender Pathak & Kamla Pathak. (2023) Anticancer potential of indole derivatives: an update. Physical Sciences Reviews 8:8, pages 1545-1569.
Crossref
Md Shahid Ayaz, Ritu Bhupal, Priyanka Sharma, Adarsh Sahu, Parwati Singh, Ghanshyam Das Gupta & Vivek Asati. (2023) Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent. Anti-Cancer Agents in Medicinal Chemistry 23:8, pages 900-921.
Crossref
Danilo Rocco, Luigi Sapio, Luigi Della Gravara, Silvio Naviglio & Cesare Gridelli. (2023) Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes. International Journal of Molecular Sciences 24:3, pages 2433.
Crossref
Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Agnese Montanino, Raffaele Costanzo, Claudia Sandomenico, Rossella De Cecio, Maria Carmela Piccirillo, Carmine La Manna, Giuseppe Totaro, Paolo Muto, Carmine Picone, Roberto Bianco, Nicola Normanno & Alessandro Morabito. (2021) RET Inhibitors in Non-Small-Cell Lung Cancer. Cancers 13:17, pages 4415.
Crossref
Fangdi Sun & Caroline E. McCoach. (2021) Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. Current Treatment Options in Oncology 22:8.
Crossref
Chang Lu & Qing Zhou. (2021) Diagnostics, therapeutics and RET inhibitor resistance for RET fusion–positive non-small cell lung cancers and future perspectives. Cancer Treatment Reviews 96, pages 102153.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.